We are live on ! Find out more
LAB icon

Standard BioTools
LAB

135 hedge funds and large institutions have $864M invested in Standard BioTools in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 43 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 23

26% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 43

8.48% more ownership

Funds ownership: 93.19% → 101.67% (+8.5%)

3% more funds holding

Funds holding: 131 → 135 (+4)

1% more capital invested

Capital invested by funds: $854M → $864M (+$10.1M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

97% less call options, than puts

Call options by funds: $6K | Put options by funds: $196K

Holders
135
Holders Change
+4
Holders Change %
+3.05%
% of All Funds
2.93%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
29
Increased
54
Reduced
43
Closed
23
Calls
$6K
Puts
$196K
Net Calls
-$190K
Net Calls Change
-$452K

Top Buyers

1
BlackRock
BlackRock
New York
+$29.2M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$21.8M
3
Morgan Stanley
Morgan Stanley
New York
+$19M
4
N
Nuveen
North Carolina
+$14.3M
5
State Street
State Street
Massachusetts
+$9.18M

Top Sellers

1
EIP
Easterly Investment Partners
Massachusetts
-$18.2M
2
Deutsche Bank
Deutsche Bank
Germany
-$10.7M
3
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$9.3M
4
SSA
Schonfeld Strategic Advisors
New York
-$7.08M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
LTFS
126
Ladenburg Thalmann Financial Services
Florida
$21K +$1.4K +110 +7%
DWA
127
Dorsey Wright & Associates
California
$16K +$4.1K +322 +33%
PA
128
Parallel Advisors
California
$13K +$13.7K +1,076 New
Royal Bank of Canada
129
Royal Bank of Canada
Ontario, Canada
$12K +$11.6K +912 New
AS
130
Altshuler Shaham
Israel
$9K +$611 +48 +7%
AG
131
Advisor Group
Arizona
$7K – – –
NIT
132
NumerixS Investment Technologies
British Columbia, Canada
$6K -$274K -21,500 -98%
PHK
133
Point72 Hong Kong
Hong Kong
$1K +$1.3K +102 New
GCP
134
GSA Capital Partners
United Kingdom
– -$823K -61,910 Closed
BCM
135
Bridgeway Capital Management
Texas
– -$730K -54,945 Closed
SCA
136
Secor Capital Advisors
New York
– -$673K -50,610 Closed
TI
137
Trexquant Investment
Connecticut
– -$645K -48,538 Closed
Walleye Trading
138
Walleye Trading
New York
– -$385K -28,988 Closed
CANY
139
Caxton Associates (New York)
New York
– -$371K -27,920 Closed
TA
140
Tiedemann Advisors
New York
– -$359K -27,037 Closed
BCM
141
Bayesian Capital Management
New York
– -$344K -25,870 Closed
Brown Advisory
142
Brown Advisory
Maryland
– -$212K -15,944 Closed
ECM
143
Element Capital Management
New York
– -$199K -14,949 Closed
Walleye Capital
144
Walleye Capital
New York
– -$195K -14,700 Closed
SPC
145
Sigma Planning Corp
Michigan
– -$177K -13,352 Closed
Man Group
146
Man Group
United Kingdom
– -$177K -13,295 Closed
II
147
Ibex Investors
Colorado
– -$175K -13,188 Closed
JT
148
Jump Trading
Illinois
– -$173K -13,000 Closed
PTC
149
Petrus Trust Company
Texas
– -$170K -12,756 Closed
MWNA
150
Marshall Wace North America
New York
– -$159K -12,003 Closed
3 4 5
6
7

LAB Hedge Fund Activity: Q2 2019 in Review

135 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2019, worth a combined $864M — up 1.2% from $854M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new LAB positions and 23 closed out — a net gain of 6 holders — while 54 added to existing stakes and 43 trimmed.

The largest buyer was BlackRock, adding an estimated $29.2M. The largest seller was Easterly Investment Partners, cutting an estimated $18.2M.

  • 135 institutional investors held Standard BioTools (LAB) as of Q2 2019, up from 131 in Q1 2019.
  • Funds reported $864M of Standard BioTools stock for Q2 2019, up 1.2% quarter-over-quarter.
  • 29 funds opened new Standard BioTools positions in Q2 2019 and 23 closed out, a net change of +6 holders.
  • The largest Standard BioTools buyer in Q2 2019 was BlackRock, an estimated $29.2M added.
  • The largest Standard BioTools seller in Q2 2019 was Easterly Investment Partners, an estimated $18.2M sold.

Based on aggregated 13F filings for Q2 2019.